ClinConnect ClinConnect Logo
Search / Trial NCT06846190

Modified Constraint Induced Movement Therapy Versus Virtual Reality Training in Children With Cerebral Palsy

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Feb 24, 2025

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Cerebral Palsy Hemiplegic Modified Constraint Induced Movement Therapy Spastic Virtual Reality

ClinConnect Summary

This clinical trial is exploring two different therapy techniques to help children with hemiplegic cerebral palsy, a condition that affects movement on one side of the body. The study is comparing modified Constraint Induced Movement Therapy (mCIMT) with virtual reality training. Both approaches aim to improve the ability of children aged 5 to 16 years to use their affected arm more effectively in daily activities. Participants will be randomly assigned to one of the two therapy groups, where they will participate in sessions three times a week for four weeks, each lasting about 1.5 hours.

To be eligible for this trial, children must be between 5 and 16 years old and have a diagnosis of spastic hemiparetic cerebral palsy. They should be able to move their wrist and fingers to some extent, and their level of movement should be more limited on one side. Children with certain health issues or recent medical treatments related to their condition may not qualify. Throughout the study, researchers will gather information on how well each therapy works by using questionnaires to assess the children's hand use and daily activities. The study will last for six months, and participants will be helping to find out which treatment might be more effective for improving movement in children with this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age range between 5 to 16 years of age.
  • Medical diagnosis of spastic hemiparetic CP.
  • At least 20◦wrist and 10◦ active finger extension from full flexion.
  • More movement deficits in 1 upper extremity (less than 2.5 on the Amount of Use scale (AOU) on the Pediatric Motor Activity Log (PMAL)).
  • Muscle tone less than 3 on the Modified Ashworth Scale.
  • Normal or corrected-to-normal vision and hearing.
  • Classified level I, II, or III of the Manual Ability Classification System ( MACS) for Children with CP
  • Exclusion Criteria:
  • Health problems not associated with CP.
  • Seizure hemispatial neglect.
  • Orthopaedic surgery on the involved upper extremity.
  • Botulinum toxin therapy for the affected upper extremity within the past 6 months or within the study period.
  • Balance problems

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Lahore, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Maria Amjad, MS-PPT

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported